Showing results (81-90 of 95) with videos related to
Sort By:
Pageof 10
HLA|June 18, 2024
Individual HLAs affect survival after allogeneic stem cell transplantation in adult T-cell leukaemia/lymphomaSatoko Morishima, Makoto Yoshimitsu, Takero Shindo, et al.Transplantation and Cellular Therapy|July 18, 2021
A Phase I/II Multicenter Trial of HLA-Haploidentical PBSCT with PTCy for Aggressive Adult T Cell Leukemia/LymphomaTakashi Tanaka, Hirohisa Nakamae, Ayumu Ito, et al.Blood Advances|January 26, 2021
Chromosomal defects and survival in patients with adult T-cell leukemia/lymphoma after allogeneic HSCTNobuaki Nakano, Atae Utsunomiya, Keitaro Matsuo, et al.International Journal of Hematology|December 14, 2022
Effect of the COVID-19 pandemic on allogeneic stem cell transplantation in JapanYoshimitsu Shimomura, Tetsuhisa Kitamura, Masashi Nishikubo, et al.The Lancet Regional Health. Western Pacific|December 18, 2023
Outcomes in human T-cell leukemia virus type I carriers after hematopoietic stem cell transplantation for diseases other than adult T cell leukemia/lymphoma: a Japanese national surveyNobuaki Nakano, Hideki Nakasone, Shigeo Fuji, et al.British Journal of Haematology|June 16, 2026
Improvements over time in survival after post-transplant relapse of adult T-cell leukaemia/lymphoma and trends of salvage therapy in a real-world experienceHidehiro Itonaga, Takuya Fukushima, Koji Kato, et al.Blood Advances|September 9, 2021
Improved survival of patients with aggressive ATL by increased use of allo-HCT: a prospective observational studyAyumu Ito, Nobuaki Nakano, Takashi Tanaka, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 12, 2022
Immunogenicity of three versus four doses of 13-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine in allogeneic haematopoietic stem cell transplantation recipients: a multicentre, randomized controlled trialKeiji Okinaka, Yukihiro Akeda, Yoshihiro Inamoto, et al.British Journal of Haematology|October 19, 2023
The prognosis and risk factors for patients with complex karyotype myelodysplastic syndrome undergoing allogeneic haematopoietic stem cell transplantationYoshimitsu Shimomura, Sho Komukai, Tetsuhisa Kitamura, et al.British Journal of Haematology|October 19, 2024
Comparative outcomes of various transplantation platforms, highlighting haploidentical transplants with post-transplantation cyclophosphamide for adult T-cell leukaemia/lymphomaMakoto Yoshimitsu, Takashi Tanaka, Nobuaki Nakano, et al.Pageof 10